References
- Chen H, Hu XY, Zhang YX, et al. (2008). Effect of chain density and conformation on protein adsorption at PEG-grafted polyurethane surfaces. Colloid Surf B Biointerfaces 61:237–43
- Chen H, Yuan L, Song W, et al. (2008). Biocompatible polymer materials: role of protein–surface interactions. Prog Polym Sci 33:1059–87
- Danhier F, Vroman B, Lecouturier N, et al. (2009). Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel. J Control Release 140:166–73
- Essa S, Rabanel JM, Hildgen P. (2011). Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density. Int J Pharm 411:178–87
- Fang C, Shi B, Pei YY, et al. (2006). In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27–36
- Fang J, Nakamura H, Maeda H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–51
- Gu F, Zhang L, Teply BA, et al. (2008). Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci USA 105:2586–91
- He CB, Hu YP, Yin LC, et al. (2010). Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–66
- Heldin CH, Rubin K, Pietras K, Ostman A. (2004). High interstitial fluid pressure-an obstacle in cancer therapy. Nature 4:806–13
- Kato K, Uchida E, Kang ET, et al. (2003). Polymer surface with graft chains. Prog Polym Sci 28:209–59
- Koide H, Asai T, Hatanaka K, et al. (2008). Particle size-dependent triggering of accelerated blood clearance phenomenon. Int J Pharm 362:197–200
- Maruyama K. (2011). Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63:161–9
- Mu L, Feng SS. (2002). Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). J Control Release 80:129–44
- Owens DE, Peppas NA. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
- Patil YB, Toti US, Khdair A, et al. (2009). Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 30:859–66
- Roser M, Fischer D, Kissel T. (1998). Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255–63
- Ruenraroengsak P, Cook JM, Florence AT. (2010). Nanosystem drug targeting: facing up to complex realities. J Control Release 141:265–76
- Sawant RR, Sawant RM, Kale AA, Torchilin VP. (2008). The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells. J Drug Target 16:596–600
- Shen Z, Yan L, Kohama K, et al. (2011). Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres. Pharmacol Res 63:51–8
- Sheng Y, Liu CS, Yuan Y, et al. (2009). Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 30:2340–8
- Sun B, Ranganathan B, Feng SS. (2008). Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 29:475–86
- Turk MJ, Waters DJ, Low PS. (2004). Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett 213:165–72
- Tziampazis E, Kohn J, Moghe PV. (2000). PEG-variant biomaterials as selectively adhesive protein templates: model surfaces for controlled cell adhesion and migration. Biomaterials 21:511–20
- Wang M, Thanou M. (2010). Targeting nanoparticles to cancer. Pharmacol Res 62:90–9
- Weitman SD, Lark RH, Coney LR, et al. (1992). Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52:3396–401
- Yao HJ, Ju RJ, Wang XX, et al. (2011). The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 32:3285–302
- Zhao ZM, He M, Yin LC, et al. (2009). Biodegradable nanoparticles based on linoleic acid and poly(β-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs. Biomacromolecules 10:565–72